73 related articles for article (PubMed ID: 24922085)
1. Determination of plasma protein binding of positron emission tomography radioligands by high-performance frontal analysis.
Amini N; Nakao R; Schou M; Halldin C
J Pharm Biomed Anal; 2014 Sep; 98():140-3. PubMed ID: 24922085
[TBL] [Abstract][Full Text] [Related]
2. Direct plasma metabolite analysis of positron emission tomography radioligands by micellar liquid chromatography with radiometric detection.
Nakao R; Schou M; Halldin C
Anal Chem; 2012 Apr; 84(7):3222-30. PubMed ID: 22409870
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous determination of protein-free and total positron emission tomography radioligand concentrations in plasma using high-performance frontal analysis followed by mixed micellar liquid chromatography: application to [11C]PBR28 in human plasma.
Nakao R; Amini N; Halldin C
Anal Chem; 2013 Sep; 85(18):8728-34. PubMed ID: 23978238
[TBL] [Abstract][Full Text] [Related]
4. Improved radiometabolite analysis procedure for positron emission tomography (PET) radioligands using a monolithic column coupled with direct injection micellar/high submicellar liquid chromatography.
Nakao R; Halldin C
Talanta; 2013 Sep; 113():130-4. PubMed ID: 23708634
[TBL] [Abstract][Full Text] [Related]
5. Rapid metabolite analysis of positron emission tomography radioligands by direct plasma injection combining micellar cleanup with high submicellar liquid chromatography with radiometric detection.
Nakao R; Schou M; Halldin C
J Chromatogr A; 2012 Nov; 1266():76-83. PubMed ID: 23116800
[TBL] [Abstract][Full Text] [Related]
6. "Mixed" anionic and non-ionic micellar liquid chromatography for high-speed radiometabolite analysis of positron emission tomography radioligands.
Nakao R; Halldin C
J Chromatogr A; 2013 Mar; 1281():54-9. PubMed ID: 23399000
[TBL] [Abstract][Full Text] [Related]
7. A simplified radiometabolite analysis procedure for PET radioligands using a solid phase extraction with micellar medium.
Nakao R; Halldin C
Nucl Med Biol; 2013 Jul; 40(5):658-63. PubMed ID: 23602762
[TBL] [Abstract][Full Text] [Related]
8. Radiopharmaceutical chemistry for positron emission tomography.
Li Z; Conti PS
Adv Drug Deliv Rev; 2010 Aug; 62(11):1031-51. PubMed ID: 20854860
[TBL] [Abstract][Full Text] [Related]
9. Rapid and sensitive measurement of PET radioligands in plasma by fast liquid chromatography/radiometric detection.
Nakao R; Schou M; Halldin C
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 May; 895-896():116-22. PubMed ID: 22494928
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and in vivo evaluation of novel PET radioligands for imaging the endothelin-A receptor.
Mathews WB; Murugesan N; Xia J; Scheffel U; Hilton J; Ravert HT; Dannals RF; Szabo Z
J Nucl Med; 2008 Sep; 49(9):1529-36. PubMed ID: 18703610
[TBL] [Abstract][Full Text] [Related]
11. Identification of PET radiometabolites by cytochrome P450, UHPLC/Q-ToF-MS and fast radio-LC: applied to the PET radioligands [11C]flumazenil, [18F]FE-PE2I, and [11C]PBR28.
Amini N; Nakao R; Schou M; Halldin C
Anal Bioanal Chem; 2013 Feb; 405(4):1303-10. PubMed ID: 23180082
[TBL] [Abstract][Full Text] [Related]
12. A restricted access material for rapid analysis of [(11)C]-labeled radiopharmaceuticals and their metabolites in plasma.
Gillings N
Nucl Med Biol; 2009 Nov; 36(8):961-5. PubMed ID: 19875053
[TBL] [Abstract][Full Text] [Related]
13. Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.
Huang Y; Bae SA; Zhu Z; Guo N; Roth BL; Laruelle M
J Med Chem; 2005 Apr; 48(7):2559-70. PubMed ID: 15801845
[TBL] [Abstract][Full Text] [Related]
14. Brain radioligands--state of the art and new trends.
Halldin C; Gulyás B; Langer O; Farde L
Q J Nucl Med; 2001 Jun; 45(2):139-52. PubMed ID: 11476163
[TBL] [Abstract][Full Text] [Related]
15. Imaging of the striatal and extrastriatal dopamine transporter with (18)F-LBT-999: quantification, biodistribution, and radiation dosimetry in nonhuman primates.
Varrone A; Stepanov V; Nakao R; Tóth M; Gulyás B; Emond P; Deloye JB; Vercouillie J; Stabin MG; Jonsson C; Guilloteau D; Halldin C
J Nucl Med; 2011 Aug; 52(8):1313-21. PubMed ID: 21764797
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of 11C, 18F, 15O, and 13N radiolabels for positron emission tomography.
Miller PW; Long NJ; Vilar R; Gee AD
Angew Chem Int Ed Engl; 2008; 47(47):8998-9033. PubMed ID: 18988199
[TBL] [Abstract][Full Text] [Related]
17. Ultrafast LC method for purification and metabolite analysis of PET probes.
Nakao R; Ito T; Hayashi K; Fukumura T; Suzuki K
Nucl Med Biol; 2010 Jan; 37(1):67-72. PubMed ID: 20122670
[TBL] [Abstract][Full Text] [Related]
18. Radioligand development for molecular imaging of the central nervous system with positron emission tomography.
Honer M; Gobbi L; Martarello L; Comley RA
Drug Discov Today; 2014 Dec; 19(12):1936-44. PubMed ID: 25173703
[TBL] [Abstract][Full Text] [Related]
19. Development of N-[11C]methylamino 4-hydroxy-2(1H)-quinolone derivatives as PET radioligands for the glycine-binding site of NMDA receptors.
Fuchigami T; Haradahira T; Fujimoto N; Nojiri Y; Mukai T; Yamamoto F; Okauchi T; Maeda J; Suzuki K; Suhara T; Yamaguchi H; Ogawa M; Magata Y; Maeda M
Bioorg Med Chem; 2009 Aug; 17(15):5665-75. PubMed ID: 19586774
[TBL] [Abstract][Full Text] [Related]
20. Sample preparation techniques for protein binding measurement in radiopharmaceutical approaches: A short review.
Moein MM; Halldin C
Talanta; 2020 Nov; 219():121220. PubMed ID: 32887121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
